JAMA Oncology NOW AVAILABLE at The Christie @JAMAOnc

We are excited to announce an early Christmas present for many of our staff who requested it, we have now got a subscription to JAMA Oncology, which is proving to be an incredibly popular new journal.

Here are some articles that have been co-authored by Christie staff and published in JAMA Oncology so far:

Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: the ARISER randomized clinical trial.

Association of survival benefit with docetaxel in prostate cancer and total number of cycles administered: a post hoc analysis of the Mainsail Study.

Clinical outcomes and survival following treatment of metastatic castrate-refractory prostate cancer with docetaxel alone or with strontium-89, zoledronic acid, or both: the TRAPEZE randomized clinical trial.

Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial.

To browse and download the latest content from JAMA Oncology, ensure you have your OpenAthens account handy and simply click below.

BROWSE JAMA ONCOLOGY